TSLA +5.2% , no news, looks to be closing the gap lower from the 6th
ZU +49% being acquired: ENGLEWOOD, Colo. & SEATTLE --(BUSINESS WIRE)-- Liberty Interactive Corporation (Liberty Interactive) (Nasdaq: QVCA, QVCB, LVNTA, LVNTB) and zulily, inc. (zulily) (Nasdaq: ZU) today announced that they have entered into a definitive agreement (the Agreement) under which Liberty Interactive will acquire all outstanding shares of zulily for $18.75 per share. The acquisition will be attributed to Liberty Interactives QVC Group tracking stock.
KITE +3.4% SANTA MONICA, Calif. , Aug. 17, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Kite) (Nasdaq:KITE) today provided an update from the Company's ongoing Phase 1/2 clinical trial of KTE-C19 in patients with refractory aggressive non-Hodgkin's lymphoma (NHL) who have failed prior chemotherapy treatments and have a poor prognosis. KTE-C19 is an investigational therapy in which a patient's T cells are genetically modified to express a Chimeric Antigen Receptor (CAR) designed to target the antigen CD19, a protein expressed on the cell surface of B-cell lymphomas and leukemias.
AVEO +118% (Caution, penny stock) : CAMBRIDGE, Mass. --(BUSINESS WIRE)-- AVEO Oncology (NASDAQ:AVEO) today announced an exclusive, worldwide license agreement with Novartis for the development and commercialization of AVEOs first-in-class, potent, humanized inhibitory antibody targeting growth differentiation factor 15 (GDF15), AV-380, and related antibodies, including modified or derivative forms of any such antibody (the Product).
Submitted August 17, 2015 at 09:07AM by StockJock-e http://ift.tt/1EyqP0g
No comments:
Post a Comment